Pathogenesis of Liver Fibrosis
The DOI matches its Crossref record; 220 of the 222 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Liver fibrosis is a major cause of morbidity and mortality worldwide due to chronic viral hepatitis and, more recently, from fatty liver disease associated with obesity. Hepatic stellate cell activation represents a critical event in fibrosis because these cells become the primary source of extracellular matrix in liver upon injury. Use of cell-culture and animal models has expanded our understanding of the mechanisms underlying stellate cell activation and has shed new light on genetic regulation, the contribution of immune signaling, and the potential reversibility of the disease. As pathways of fibrogenesis are increasingly clarified, the key challenge will be translating new advances into the development of antifibrotic therapies for patients with chronic liver disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“STAT3, a member of the STATs family, is a key transcriptional mediator of cellular processes [43, 44].”
From Saikosaponin b1 Attenuates Liver Fibrosis by Blocking STAT3/Gli1 Interaction and Inducing Gli1 Degradation (2025) · cites this paper as [43]
In the citing paper
“they may also derive from portal fibroblasts, bone marrow-derived cells, circulating fibrocytes, [7] and by the controversially discussed epithelial-tomesenchymal (EMT) [8,9] or endothelial-to-mesenchymal (EndoTM) transition.[10,11]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [7]
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Origins and Mechanisms of miRNAs and siRNAs
Carthew, R. W., & Sontheimer, E. J. (2009) · Cell · doi:10.1016/j.cell.2009.01.035 · Cited by 5,018
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Self-citationMany roads to maturity: microRNA biogenesis pathways and their regulation
Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009) · Nature Cell Biology · doi:10.1038/ncb0309-228 · Cited by 2,656
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Self-citationEndothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Bendelac, A., Savage, P. B., & Teyton, L. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,155
Research works printed but not linked: 15
- 10.1172/jci200112373 · DOI · Paper page
- 10.1055/s-2001-17556 · DOI · Paper page
- Stupack DG., 2007, Oncology, 21, 6
- Hehlgans S, 2007, Biochim. Biophys. Acta, 1775, 163
- Omenetti A, 2008, J. Clin. Investig., 118, 3331
- Pinzani M, 1996, Am. J. Pathol., 148, 785
- Sims DE., 1991, Can. J. Cardiol., 7, 431
- Thimgan MS, 1999, Am. J. Physiol., 277, G137
- 10.1136/gut.2005.088690 · DOI · Paper page
- Gao B., 2005, Cell Mol. Immunol., 2, 92
- Anania FA, 1995, Hepatology, 21, 1640
- Connolly MK, 2009, J. Clin. Investig., 119, 3213
- Seki E, 2009, J. Clin. Investig., 119, 1858
- McCrudden R, 2000, Histol. Histopathol., 15, 1159
- 10.1002/hep.23046 · DOI · Paper page
Cited by
Items 701–800 of 1,007
Long, T., Wang, L., Yang, Y., Yuan, L., Zhao, H., Chang, C., Yang, G., Ho, C., & Li, S. (2019) · Food & Function · doi:10.1039/c9fo01010f · Cited by 29
Li, X., Chen, R., Kemper, S., & Brigstock, D. R. (2020) · Cells · doi:10.3390/cells9020290 · Cited by 31
“Hepatic fibrosis is the result of chronic liver injury and is characterized by the deposition of collagen and other insoluble extracellular matrix components [1].”
BackgroundTao, H.-C., Chen, K., Wang, X., Chen, B., Zhao, W., Zheng, Y., & Yang, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00148 · Cited by 29
“Although the mechanism for linking inflammation and fibrosis has not yet been fully clarified, liver damage–induced activation of resident inflammatory cells and recruitment of monocytes/macrophages have been reported to promote the development of fibrosis (4).”
BackgroundMa, L., Liu, J., Xiao, E., Ning, H., Li, K., Shang, J., & Kang, Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119144 · Cited by 29
Biliary fibrosis drives liver repopulation and phenotype transition of transplanted hepatocytes
Yovchev, M. I., Locker, J. D., & Oertel, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.036 · Cited by 29
Qiao, H., Zhou, Y., Qin, X., Cheng, J., He, Y., & Jiang, Y. (2018) · Stem Cells International · doi:10.1155/2018/1239143 · Cited by 28
Protective effects of theasinensin A against carbon tetrachloride-induced liver injury in mice
Hung, W., Yang, G., Wang, Y.-C., Chiou, Y., Tung, Y., Yang, M., Wang, B., Ho, C., Wang, Y., & Pan, M. (2017) · Food & Function · doi:10.1039/c7fo00700k · Cited by 28
Emodin Alleviates Liver Fibrosis of Mice by Reducing Infiltration of Gr1hi Monocytes
Zhao, X., Chen, G., Liu, Y., Wu, H., Chen, J., Xiong, Y., Tian, C., Jia, B., Wang, G., Xia, J., et al. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/5738101 · Cited by 28
“TGF-β1 is considered to be the most potent profibrogenic cytokine [38, 39].”
BackgroundWu, W., Wang, T., Sun, B., Liu, D., Lin, Z., Miao, Y., Wang, C., Geng, X., & Li, B. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.111910 · Cited by 28
Zhong, H., Gui, X., Hou, L., Lv, R., & Jin, Y. (2022) · Pathogens · doi:10.3390/pathogens11030289 · Cited by 28
“Damaged HSCs exhibits a proliferative and fibrogenic myofibroblast-like phenotype, which can be confirmed by the expression of α-SMA [100].”
BackgroundSuppressing circ_0008494 inhibits HSCs activation by regulating the miR-185-3p/Col1a1 axis
Li, B., Zhou, J., Luo, Y., Tao, K., Zhang, L., Zhao, Y., Lin, Y., Zeng, X. Y., & Yu, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1050093 · Cited by 28
“The deposition of type I and type III collagens not only continuously activates HSCs but also keeps them in an active state, thereby causing hepatocyte dysfunction (Hernandez-Gea and Friedman, 2011).”
BackgroundLi, B., Huang, Y., Bao, J., Xu, Z., Yan, X., & Zou, Q. (2023) · Small · doi:10.1002/smll.202304675 · Cited by 28
Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine
Zheng, S., Xue, C., Li, S., Zao, X., Li, X., Liu, Q., Cao, X., Wang, W., Qi, W., Du, H., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1381476 · Cited by 29
Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation
Aher, J., Khan, S., Jain, S., Tikoo, K., & Jena, G. (2014) · Human & Experimental Toxicology · doi:10.1177/0960327114531992 · Cited by 30
“Ultimately, progression of the hepatic fibrosis culminates into end-stage, that is, hepatic cirrhosis.(3) Although extensive studies have been conducted on hepatic fibrosis, very little success has been achieved in the clinical treatment.”
BackgroundNovel Insights Into TRPM7 Function in Fibrotic Diseases: A Potential Therapeutic Target
Xu, T., Wu, B., Yao, H.-W., Meng, X., Huang, C. Z., Ni, M.-M., & Li, J. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24801 · Cited by 28
PTP1B confers liver fibrosis by regulating the activation of hepatic stellate cells
Chen, P., Cai, S.-P., Yang, Y., Li, W., Huang, C., Meng, X., & Li, J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.12.021 · Cited by 28
Mohammadalipour, A., Karimi, J., Khodadadi, I., Solgi, G., Hashemnia, M., Sheikh, N., & Bahabadi, M. (2016) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2016.1263860 · Cited by 28
Ma, T., Cai, X., Wang, Z., Huang, L., Wang, C., Jiang, S., Hua, Y., & Liu, Q. (2017) · BioMed Research International · doi:10.1155/2017/2670658 · Cited by 28
Zeng, J., Zhu, B., & Su, M. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.094 · Cited by 28
Han, K., Zhang, Y., & Yang, Z. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7207 · Cited by 28
Mechanism of Fibrosis Induced by Echinococcus spp.
Niu, F., Chong, S., Qin, M., Li, S., Wei, R., & Zhao, Y. (2019) · Diseases · doi:10.3390/diseases7030051 · Cited by 28
Liu, Y.-T., & Lv, W. (2019) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-019-3039-1 · Cited by 28
Ocker, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i3.279 · Cited by 29
Tong, M., Zheng, Q. Y., Liu, M., Chen, L., Lin, Y., Tang, S., & Zhu, Y. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1897241 · Cited by 28
Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice
Quillin, R. C., Wilson, G. C., Nojima, H., Freeman, C. M., Wang, J., Schuster, R. M., Blanchard, J. A., Edwards, M. J., Gandhi, C. R., Gulbins, E., et al. (2014) · Hepatology Research · doi:10.1111/hepr.12352 · Cited by 28
Curcumin affects β-catenin pathway in hepatic stellate cell in vitro and in vivo
Cui, L., Jia, X., Zhou, Q., Zhai, X., Zhou, Y., & Zhu, H. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12283 · Cited by 28
“HSC activation is the key event in the development of liver fibrosis because activated HSCs are the primary source of ECM such as collagen.([8]) Although many researches focus on liver fibrosis, very few breakthroughs have occurred in therapeutic intervention of this disease.”
BackgroundInhibition of IRF3 expression reduces TGF-β1-induced proliferation of hepatic stellate cells
Ni, M.-M., Xu, T., Wang, Y.-R., He, Y.-H., Zhou, Q. Y., Huang, C., Meng, X., & Li, J. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0452-6 · Cited by 28
Yu, X., Elfimova, N., Müller, M., Bachurski, D., Koitzsch, U., Drebber, U., Mahabir, E., Hansen, H. P., Friedman, S. L., Klein, S., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.02.013 · Cited by 27
Self-citationKang, R., Tian, W., Cao, W., Sun, Y., Zhang, H., Feng, Y.-D., Li, C., Li, Z., & Li, X. (2021) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(21)60018-3 · Cited by 27
Sarma, M. S., & Seetharaman, J. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i10.1269 · Cited by 27
Huang, T., Li, Y.-Q.-X., Zhou, M., Hu, R.-H., Zou, G.-L., Li, J.-C., Feng, S. Y., Liu, Y., Xin, C.-Q., & Zhao, X. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i1.123 · Cited by 27
Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy
Ojha, S., Přibyl, J., Klimovič, Š., Hadraba, D., Jiroušková, M., & Gregor, M. (2022) · Journal of Visualized Experiments · doi:10.3791/63974 · Cited by 27
Abdelnabi, M. N., Molina, M. F., Soucy, G., Trinh, V. Q., Bédard, N., Mazouz, S., Jouvet, N., Dion, J., Tran, S., Bilodeau, M., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.08.001 · Cited by 27
Hepatocyte-specific Prominin-1 protects against liver injury-induced fibrosis by stabilizing SMAD7
Lee, H., Yu, D., Bahn, M., Kwon, Y.-J., Um, M. J., Yoon, S. Y., Kim, K., Lee, M., Jo, S.-J., Lee, S., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00831-y · Cited by 27
Cao, Y., Yang, H., Huang, Y., Lu, J., Du, H., & Wang, B. (2024) · Open Medicine · doi:10.1515/med-2024-0945 · Cited by 28
Microvascular targets for anti-fibrotic therapeutics.
Pu, K.-M., Sava, P., & Gonzalez, A. L. (2013) · PubMed Central · Cited by 29
Mechanisms of hepatitis C virus-related insulin resistance
Negro, F. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.01.011 · Cited by 27
Li, Y., Luo, Y., Zhang, X., Lin, X., He, M., & Liao, M. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141020543 · Cited by 27
Early to Phase II drugs currently under investigation for the treatment of liver fibrosis
Hauff, P., Gottwald, U., & Ocker, M. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.997874 · Cited by 27
Li, Z., Sun, J., Chen, L., Huang, N., Hu, P., Hu, X., Han, G., Zhou, Y., Bai, W., Niu, T., et al. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25132 · Cited by 27
Cirrhosis and Advanced Fibrosis in Hispanics in Texas: The Dominant Contribution of Central Obesity
Jiao, J., Watt, G. P., Lee, M., Rahbar, M. H., Vatcheva, K. P., Pan, J., McCormick, J. B., Fisher‐Hoch, S. P., Fallon, M. B., & Beretta, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150978 · Cited by 28
Astragaloside Ⅳ combating liver cirrhosis through the PI3K/Akt/mTOR signaling pathway
Wei, R., Liu, H., Chen, R., Sheng, Y., & Liu, T. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6966 · Cited by 27
Wang, A., Zhou, F., Li, D., Lu, J., Wang, Y., & Lin, L. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.11.011 · Cited by 27
Raffaele, M., Carota, G., Sferrazzo, G., Licari, M., Barbagallo, I. A., Sorrenti, V., Signorelli, S. S., & Vanella, L. (2019) · Antioxidants · doi:10.3390/antiox8080277 · Cited by 27
“In the case of repeated damage, liver parenchyma could respond with an excessive extracellular matrix (ECM) accumulation, due to activation of hepatic stellate cells (HSCs) in perisinusoidal space [18,19].”
BackgroundChen, C., Li, X., & Wang, L. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.08.014 · Cited by 27
Lin, H., Fan, T., Sui, J. H., Wang, G., Chen, J., Zhuo, S., & Zhang, H. (2019) · Nanoscale · doi:10.1039/c9nr04902a · Cited by 27
Using Zebrafish as a Disease Model to Study Fibrotic Disease
Wang, X., Copmans, D., & de Witte, P. A. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126404 · Cited by 27
Wu, J., Zhang, D., Zhu, B., Wang, S., Xu, Y., Zhang, C., Yang, H., Wang, S., Liu, P., Qin, L., et al. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00607-6 · Cited by 27
“It might be employed to treat liver fibrosis in a clinical setting if HSCs activation could be decreased, or perhaps the active status of HSCs could be driven back to a static condition [1, 7, 8].”
BackgroundBahrami, A. J., Gunaje, J. J., Hayes, B. J., Riehle, K. J., Kenerson, H. L., Yeung, R. S. W., Stempien‐Otero, A., Campbell, J. S., & Mahoney, W. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108505 · Cited by 27
Manojlovic, Z., Blackmon, J., & Stefanovic, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065897 · Cited by 27
Attallah, A. M., El-Far, M., Malak, C. A. A., Omran, M. M., Farid, K., Hussien, M. A., Albannan, M. S., Attallah, A. A., Elbendary, M. S., Elbesh, D. A., et al. (2015) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30785-9 · Cited by 27
Ke, B.-J., & Lee, C.-L. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.02.010 · Cited by 27
Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats
Ohara, M., Ohnishi, S., Hosono, H., Yamamoto, K., Fu, Q., Maehara, O., Suda, G., & Sakamoto, N. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00709 · Cited by 27
“293/hTLR4A-MD2-CD14 cells were activated by lipopolysaccharide (LPS; Sigma-Aldrich, St. Louis, MO, United States) treatment.”
BackgroundInfluentialShao, M., Zhang, X., Sun, J., Dong, H., Han, X., Yang, Q., Chen, R., Shen, L., Xu, L., Wang, L., et al. (2025) · Exploration · doi:10.1002/exp.70000 · Cited by 26
Spermidine Prevents Ethanol and Lipopolysaccharide-Induced Hepatic Injury in Mice
Adhikari, R., Shah, R., Reyes‐Gordillo, K., Arellanes‐Robledo, J., Cheng, Y., Ibrahim, J., & Tuma, P. L. (2021) · Molecules · doi:10.3390/molecules26061786 · Cited by 26
Salidroside in the Treatment of NAFLD/NASH
Qu, B., Liu, X., Liang, Y., Zheng, K., Zhang, C., & Lu, L. (2022) · Chemistry & Biodiversity · doi:10.1002/cbdv.202200401 · Cited by 26
Zhang, W., Kong, X., Wang, Z. J., Luo, S. J., Huang, W., & Zhang, L. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129621 · Cited by 26
Lamontagne, A., Long, R. E., Comunale, M. A., Hafner, J., Rodemich-Betesh, L., Wang, M., Marrero, J. A., Bisceglie, A. M. D., Block, T. M., & Mehta, A. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064992 · Cited by 27
Zhu, X., Zhang, F., Zhou, L., Kong, D., Chen, L., Lu, Y., & Zheng, S. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-0959-3 · Cited by 26
Wu, C., Lin, Y., & Huang, Y. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24392 · Cited by 26
Liu, Z., Jian, Y., Ye, R., Liu, J., Duan, Q., Xiao, J., & Liu, F. (2015) · Europe PMC (PubMed Central) · Cited by 26
Immune Regulation of Intrahepatic Regulatory T Cells in Fibrotic Livers of Mice
Zhang, X., Lou, J., Bai, L., Chen, Y., Zheng, S., & Duan, Z. (2017) · Medical Science Monitor · doi:10.12659/msm.899725 · Cited by 26
Bodhankar, S. L., Kandhare, A. D., Mohan, V., & Thakurdesai, P. A. (2017) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.214688 · Cited by 26
IL-22 inactivates hepatic stellate cells via downregulation of the TGF-β1/Notch signaling pathway
Chen, E., Cen, Y., Lu, D., Luo, W., & Jiang, H.-X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8516 · Cited by 26
Gaining New Biological and Therapeutic Applications into the Liver with 3D In Vitro Liver Models
Lee, S. W., Jung, D. J., & Jeong, G. S. (2020) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-020-00245-9 · Cited by 26
Yan, Z., Wang, D., An, C., Xu, H., Zhao, Q., Shi, Y., Song, N., Deng, B., Guo, X., Rao, J., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.07.004 · Cited by 26
Tao, X., Li, D., Zhang, C., Wen, G.-H., Wu, C., Xu, Y., Kan, Y., Lu, W., Ding, H., & Yang, Y. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9772 · Cited by 26
Extracellular vesicles: catching the light of intercellular communication in fibrotic liver diseases
Li, Y., Wu, J., Liu, R., Zhang, Y., & Li, X. (2022) · Theranostics · doi:10.7150/thno.77256 · Cited by 26
Protective effects of thymosin β4 on carbon tetrachloride‐induced acute hepatotoxicity in rats
Reyes‐Gordillo, K., Shah, R., Arellanes‐Robledo, J., Rojkind, M., & Lakshman, M. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06728.x · Cited by 26
S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
de Oliveira, M. G., Mazo, D. F. D. C., Pereira, I. V. A., Cogliati, B., Stefano, J. T., Souza, Rabelo, F., Carrilho, de Oliveira, C. P. M. S., Lima, F. R., et al. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s43930 · Cited by 26
Kong, X. Y., Nesset, C. K., Daμμe, M., Løberg, E. M., Lübke, T., Mæhlen, J., Andersson, K. B., Lorenzo, P. I., Roos, N., Thoresen, G. H., et al. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.014050 · Cited by 26
Modulation of Bcl-x Alternative Splicing Induces Apoptosis of Human Hepatic Stellate Cells
Wu, L., Mao, C., & Ming, X. (2016) · BioMed Research International · doi:10.1155/2016/7478650 · Cited by 26
Reelin expression in human liver of patients with chronic hepatitis C infection
Carotti, S., Perrone, G., Amato, M., Gentilucci, U. V., Righi, D., Francesconi, M. A., Pellegrini, C., Zalfa, F., Zingariello, M., Picardi, A., et al. (2017) · European Journal of Histochemistry · doi:10.4081/ejh.2017.2745 · Cited by 26
Febres-Aldana, C. A., Alghamdi, S., Krishnamurthy, K., & Poppiti, R. J. (2019) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2018.00053 · Cited by 25
Cao, F., Zhang, Y., Li, W., Shimizu, K., Xie, H., & Zhang, C. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2017.12.023 · Cited by 25
Lyu, H., Tang, H., Liang, Y., Huang, S., Wang, Y., Huang, W., & Zhou, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.841314 · Cited by 25
“HIV can affect the immune system, thereby affecting the function of vital organs including the liver, and then induce fibrosis generation (19).”
BackgroundFisetin Ameliorates Alcohol-Induced Liver Injury through Regulating SIRT1 and SphK1 Pathway
Zhou, Z.-S., Kong, C., Sun, J.-R., Qu, X.-K., Sun, J., & Sun, A.-T. (2022) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x22500938 · Cited by 25
Delivery of hydroxycamptothecin via sonoporation: An effective therapy for liver fibrosis
Chen, Q., Huang, J., Ye, Y., Hu, A., Xu, B., Hu, D., Wang, L., Xing, L., Chen, S., Gui, X., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.002 · Cited by 26
Serum biomarkers for liver fibrosis assessment
Maroto‐García, J., Álvarez, A. M., de Pedro, M. P. S., Soto, A. B., & González, Á. (2023) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2023-0081 · Cited by 25
MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma
Li, G., Cai, G., Li, D., & Yin, W. (2013) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2013-131883 · Cited by 25
Twu, Y., Lee, T., Lin, Y., Hsu, S., Wang, Y.-H., Liao, C.-Y., Wang, C.-K., Liang, Y., & Liao, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071122 · Cited by 25
Differentiation of fibrotic liver tissue using laser-induced breakdown spectroscopy
Terán-Hinojosa, E., Sobral, H., Sanchez-Perez, C. A., Pérez-García, A., Alemán-García, N., & Hernández-Ruiz, J. (2017) · Biomedical Optics Express · doi:10.1364/boe.8.003816 · Cited by 25
Wan, Y., Ceci, L., Wu, N., Zhou, T., Chen, L., Venter, J. K., Francis, H., Bernuzzi, F., Invernizzi, P., Kyritsi, K., et al. (2019) · Laboratory Investigation · doi:10.1038/s41374-018-0178-5 · Cited by 25
Chen, L., Zhou, T., Wu, N., O’Brien, A., Venter, J. K., Ceci, L., Kyritsi, K., Onori, P., Gaudio, E., Sybenga, A. B., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.03.002 · Cited by 25
“A hallmark of liver fibrosis is the activation of HSCs, which serve as major producer of fibrogenic extracellular matrix [33].”
BackgroundSayed, N., Khurana, A., Saifi, M. A., Singh, M. S., & Godugu, C. (2019) · BioFactors · doi:10.1002/biof.1546 · Cited by 25
Kurtoğlu, E. L., Kayhan, B., Gül, M., Kayhan, B., Akdoğan, M., Karaca, Z. M., Yeşilada, E., & Yılmaz, S. (2019) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2019.18276 · Cited by 25
Li, C., Meng, M., Guo, M., Wang, M., Ju, A., & Wang, C. (2019) · RSC Advances · doi:10.1039/c9ra04679h · Cited by 25
Wang, S., Li, M., Zhao, X., Wang, H., Zhu, J., Wang, C. H., Zhou, M., Dong, H., & Zhou, R. (2020) · The FASEB Journal · doi:10.1096/fj.201902438r · Cited by 25
Li, B., Meng, C., Zhu, Y., Xiong, Y., Jin, W., Wan, Y., Zhou, Y., Ao, Y., & Wang, H. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000470650 · Cited by 25
The Biological Function of Kupffer Cells in Liver Disease
Ma, Y., Yang, M., He, Z., Wei, Q., & Li, J. (2017) · InTech eBooks · doi:10.5772/67673 · Cited by 26
You, S., Zhao, J., Ma, L., Tudimat, M., Zhang, S.-L., & Liu, T. (2015) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-015-0135-4 · Cited by 25
Wang, Z., Cao, Z., Dong, Y., Hong, Y., Zuo, L., & Wang, H. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000000893 · Cited by 24
“All PDGF isoforms are upregulated during HSCs activation and markedly promote HSCs proliferation, migration, and collagen synthesis by activating PDGFR-α / β –mediated PI3K/Akt and MAPK pathways, [4,119,121–123] thus accelerating liver fibrosis progression.”
Liao, X., Zhan, W., Tian, T., Yu, L., Li, R., & Yang, Q. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29520 · Cited by 24
“Hepatic fibrosis is induced by dyshomeostasis between ECM synthesis and degradation in liver tissues, in which HSCs plays vital roles in response to chronic liver injury.(4,7) In the present study, we have explored the role of miR‐326 in HSC activation and liver fibrosis and its potential mechanism.”
BackgroundWang, A., Bu, F., Li, J., Zhang, Y., Jia, P., You, H., Wu, S., Wu, Y., Zhu, S., Huang, C. Z., et al. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.11.014 · Cited by 24
New advances of DNA/RNA methylation modification in liver fibrosis
Yang, L., Liu, Y., Sun, Y.-Y., Huang, C., Li, J., & Wang, Y. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110224 · Cited by 26
de la Torre, R. A. M. G., Vallverdú, J., Xu, Z., Ariño, S., Ferrer‐Lorente, R., Zanatto, L., Mercado-Gómez, M., Aguilar‐Bravo, B., Ruiz-Blázquez, P., Fernández, M. G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56024-4 · Cited by 24
Altomonte, J., Marozin, S., Toni, E. N. D., Rizzani, A., Esposito, I., Steiger, K., Feuchtinger, A., Hellerbrand, C., Schmid, R. M., & Ebert, O. (2013) · Molecular Therapy · doi:10.1038/mt.2013.181 · Cited by 24
Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver
Lu, S., Bennett, R. G., Kharbanda, K. K., & Harrison-Findik, D. D. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i4.211 · Cited by 24
A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses
Wang, X., Ai, L., Xu, Q., Wu, C. W., Chen, Z., Su, D., Jiang, X., & Fan, Z. (2017) · Inflammation · doi:10.1007/s10753-017-0528-2 · Cited by 24
Metadata
- Authors
- Hernandez-Gea, V., & Friedman, S. L.
- Affiliations
- Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York 10029;
- Icahn School of Medicine at Mount Sinai (US)
- ORCID
- Friedman, Scott L.
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2011-02-28
- Volume
- 6
- Issue
- 1
- Pages
- 425-456
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- OpenAlex
- W2142988890
- Cited by
- 1,809
- References
- 220
- Citations by year
- 2026: 81 · 2025: 123 · 2024: 121 · 2023: 112 · 2022: 148 · 2021: 174 · 2020: 145 · 2019: 119 · 2018: 117 · 2017: 131 · 2016: 136 · 2015: 124 · 2014: 97 · 2013: 76 · 2012: 67
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Pathology Mechanisms of Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver fibrosis, hepatic stellate cell activation, extracellular matrix, chronic viral hepatitis, hepatic steatosis, obesity, immune signaling, genetic control, fibrosis reversibility, antifibrotic therapy, chronic liver disease
- MeSH terms
- Humans, Liver, Liver Cirrhosis, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.